How Digital Health Platforms Affect Healthcare Costs

AI Health Tech Med Tech

As healthcare costs continue to go up, digital health platforms are emerging as powerful cost-cutting tools. The global digital health market size was estimated at $240.9 billion in 2023 and is projected to grow at a compound annual growth (CAGR) of 21.9% from 2024 to 2030. 

These platforms are not just fancy apps or websites. From telehealth to AI-powered diagnostics, digital health applications are changing healthcare for the better. 

How do these platforms trim the fat from our bloated healthcare system? Let’s explore the ways digital health can make healthcare more affordable for everyone.

Contents

Telemedicine: Healthcare at Your Fingertips

Telemedicine brings healthcare right to your home, office, or wherever you are. It’s like having a doctor in your pocket! But how does this convenience translate to cost savings?

Woman in green sweater talking to doctor on Zoom

Virtual doctor visits reduce travel and waiting room costs

A study published in the Journal of Medical Internet Research found that telehealth visits saved patients an average of 100 minutes of travel time and $50 in travel costs per visit (Snoswell et al., 2020).

Think about the last time you went to the doctor. How much time did you spend traveling and sitting in the waiting room? With telehealth, those time and money costs disappear. 

Fewer ER visits

How often have you wondered if that late-night stomach ache was worth a trip to the ER? Telehealth tools like AI chatbots can help you make that decision without leaving home. 

Cost savings for both patients and healthcare providers

It’s not just patients who save money. Healthcare providers benefit too. Telehealth services have been found to reduce healthcare costs for providers and patients. Even better, many insurers now have an allowance to cover the cost of certain telehealth visits.

Preventive Care: Stopping Problems Before They Start

Have you ever heard the saying “an ounce of prevention is worth a pound of cure”? Digital health platforms are making this old adage more relevant than ever.

How digital platforms promote healthy habits

Fitness app in the gym

From step counters to diet trackers, digital health apps are helping us stay healthier. But do they really make a difference? A study by Ernsting et al. (2017) found that users of health and fitness apps were 34% more likely to meet physical activity guidelines compared to non-users.

Wearable devices and their impact on early detection

glucose monitor on arm with phone app showing glucose level

Smartwatches surpass the practical use of telling time–they’re becoming powerful health monitors. For example, Apple Watch’s ECG feature can detect atrial fibrillation with 98% accuracy, potentially preventing strokes and saving lives (Perez et al., 2019).

How AI and big data can predict health risks and reduce costs

Big Data Analytics in healthcare uses AI, machine learning and deep learning tools to help doctors find the best treatments for each patient, which can reduce waste. This lets doctors predict health problems  and start treatments early, which can save lives. This could change how common certain diseases are and save money on healthcare (Batko & Ślęzak, 202​​2).

Cost savings through prevention vs. treatment

Prevention isn’t just better for our health—it’s better for our wallets too. The Centers for Disease Control and Prevention estimates that chronic diseases that are avoidable through preventive care account for 75% of the nation’s healthcare spending.

Streamlined Administrative Processes

Paperwork is no one’s favorite part of healthcare. Digital platforms are making administrative tasks faster, easier, and more cost-effective.

Automated appointment scheduling and reminders

Have you ever forgotten a doctor’s appointment? Digital reminders can help. 

Smartwatch with phone and dumbbells

Ulloa-Pérez et al. (2022) found that sending an extra text reminder for high-risk appointments reduced no-shows in primary care and mental health offices, and same-day cancellations in primary care offices. 

Targeting reminders using risk prediction models (predictive analytics) can efficiently use healthcare resources, potentially preventing hundreds of missed visits monthly. This approach saves costs compared to messaging all patients, though implementing the risk model has some costs.

Digital health records reduce paperwork and administrative errors 

Nurse charting

Remember when doctors used to write prescriptions by hand? Digital health records make all kinds of admin work more efficient. A study in the Journal of the American Medical Informatics Association found that electronic health records with AI can reduce medication and billing errors.

Cost savings through improved workflow and resource allocation

Efficient workflows mean better care at lower costs. A study in the Journal of Medical Internet Research found that digital health platforms improved hospital workflow efficiency by 25%, leading to annual cost savings of $1.2 million for a mid-sized hospital (Luo et al., 2019).

Person looking at white overlay

Data-Driven Insights for Better Decision Making

In the age of big data, information is power. Healthcare is no exception. With all this digital information, doctors can make smarter choices about your health. 

How big data analytics improve treatment plans

A study in the Journal of Big Data found that big data analytics improved treatment efficacy by 30% and reduced treatment costs by 20% (Dash et al., 2019).

Cost savings from shorter and fewer hospital stays

Nurse standing in a recovery room

Have you ever wondered how hospitals decide how many beds they need? Predictive analytics is the answer. It can reduce hospital bed shortages and decrease operational costs.

Hospital stays are expensive, but RPM can help shorten them. RPM allows patients to be discharged an average of 2 days earlier, resulting in cost savings of $7,000 per patient.

Personalized medicine and its impact on cost reduction

One size doesn’t fit all in healthcare. Targeted treatments are more effective and cost-effective. 

  • Personalized treatment plans based on genetic data improve treatment efficacy and reduce adverse drug reactions (ADRs).
ECG monitor closeup on stomach

Remote Patient Monitoring: Reducing Hospital Stays

Sometimes, the best hospital care happens outside the hospital. 

Remote patient monitoring (RPM) allows health providers to keep an eye on patients without keeping them in the hospital. From smart pills to wearable sensors, remote monitoring technologies are diverse and growing. 

Impact on reducing hospital readmissions

Nobody likes going back to the hospital. Remote monitoring can help prevent that. A study in the New England Journal of Medicine found that remote monitoring reduced hospital readmissions for heart failure patients by 50% (Perez et al., 2019).

Management of chronic conditions from home

Gentleman taking his blood pressure in tan shirt

Chronic conditions are a major driver of healthcare costs. Remote monitoring can help manage these conditions more effectively. 

A 2024 study showed that telehealth reduces healthcare costs by cutting down on hospital visits, travel time, and missed work, especially for managing chronic conditions. This benefits both patients and healthcare systems financially (Prasad Vudathaneni et al., 2024).

Increasing Access to Specialized Care

Specialized care can be hard to access, especially in rural areas. Digital health isn’t just about general care – it’s also bringing expert help to more people.

Telehealth solutions for rural and underserved areas

Rural healthcare access is a major challenge. Telehealth can help bridge that gap. A study in Health Affairs found that telehealth increased access to specialty care in rural areas by 54%.

Telehealth also faces challenges like high setup costs and outdated payment models, especially in rural areas. Its success depends on cost distribution, clinical outcomes, and indirect savings. Hospitals need funding and strategies to reach underserved groups and ensure fair access to telehealth (Anawade et al., 2024).

Virtual second opinions and their impact on treatment decisions

Getting a second opinion can be life-changing. Virtual platforms make it easier than ever. Virtual second opinions can change the diagnosis or treatment plan in over one-third of cases, potentially avoiding unnecessary procedures and costs.

Conclusion

Digital health platforms are powerful allies to counteract rising healthcare costs. By leveraging technology for prevention, efficiency, and data-driven insights, these platforms are making healthcare more accessible and affordable. From applications like telehealth reducing unnecessary ER visits to catching illnesses early with AI-powered diagnostics, the potential for cost savings is huge. 

As patients, we can embrace these digital tools to take control of our health and potentially lower our healthcare expenses. For healthcare providers, adopting these platforms could lead to more efficient operations and better patient outcomes. 

What do you think about these digital health innovations? Have you used any of these technologies in your own healthcare journey? 

References

Anawade, P. A., Sharma, D., & Gahane, S. (2024). A Comprehensive Review on Exploring the Impact of Telemedicine on Healthcare Accessibility. Cureus, 16(3). doi.org/10.7759/cureus.55996

Batko, K., & Ślęzak, A. (2022). The use of Big Data Analytics in healthcare. Journal of Big Data, 9(1). doi.org/10.1186/s40537-021-00553-4

Centers for Disease Control and Prevention. (2021). Chronic diseases in America. Retrieved from https://www.cdc.gov/chronicdisease/resources/infographic/chronic-diseases.htm

Dash, S., Shakyawar, S. K., Sharma, M., & Kaushik, S. (2019). Big data in healthcare: Management, analysis and future prospects. Journal of Big Data, 6(1), 1-25. doi.org/10.1186/s40537-019-0217-0

Ernsting, C., Dombrowski, S. U., Oedekoven, M., & Kanzler, M. (2017). Using smartphones and health apps to change and manage health behaviors: A population-based survey. Journal of Medical Internet Research, 19(4), e101.

Grand View Research. (2024). Digital Health Market Size, Share & Trends Analysis Report By Technology (Healthcare Analytics, mHealth), By Component (Hardware, Software, Services), By Application, By End-use, By Region, And Segment Forecasts, 2024 – 2030. Retrieved from https://www.grandviewresearch.com/industry-analysis/digital-health-market

Luo, L., Li, J., Liang, X., Zhang, J., & Guo, Y. (2019). A cost-effectiveness analysis of a mobile-based care model for community-dwelling elderly individuals. Journal of Medical Internet Research, 21(5), e13563.

Perez, M. V., Mahaffey, K. W., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., Balasubramanian, V., Russo, A. M., Rajmane, A., Cheung, L., Hung, G., Lee, J., Kowey, P., Talati, N., Nag, D., Gummidipundi, S. E., Beatty, A., Hills, M. T., Desai, S., … Turakhia, M. P. (2019). Large-scale assessment of a smartwatch to identify atrial fibrillation. New England Journal of Medicine, 381(20), 1909-1917.

Personalized Medicine Coalition. (2020). The personalized medicine report: Opportunity, challenges, and the future. Retrieved from http://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/The-Personalized-Medicine-Report1.pdf

Prasad Vudathaneni, V. K., Lanke, R. B., Mudaliyar, M. C., Movva, K. V., Kalluri, L. M., & Boyapati, R. (2024). The Impact of Telemedicine and Remote Patient Monitoring on Healthcare Delivery: A Comprehensive Evaluation. Cureus, 16(3). doi.org/10.7759/cureus.55534

Snoswell, C. L., Taylor, M. L., Comans, T. A., Smith, A. C., Gray, L. C., & Caffery, L. J. (2020). Determining if telehealth can reduce health system costs: Scoping review. Journal of Medical Internet Research, 22(10), e17298.

Ulloa-Pérez, E., Blasi, P. R., Westbrook, E. O., Lozano, P. , Coleman, K. F., & Coley, R. Y.  (2022). Pragmatic Randomized Study of Targeted Text Message reminders to Reduce Missed Clinic Visits. The Permanente Journal, 26(1), doi/10.7812/TPP/21.078

Winstead, E. (2023). Telehealth Can Save People with Cancer Time, Travel, and Money. National Cancer Institute. Retrieved from https://www.cancer.gov/news-events/cancer-currents-blog/2023/telehealth-cancer-care-saves-time-money

Prescription Digital Therapeutics: The Future of Digital Health Solutions

Prescription Digital Therapeutics: The Future of Digital Health Solutions

AI Health Tech Med Tech

The global market for prescription digital therapeutics (PDT) is expected to grow to $17.16 billion by 2030. This growth is mainly due to the affordability of digital health technology for both healthcare providers and patients, as well as the increasing use of smartphones in both developed and developing countries.

In this article, we’ll describe PDT, its applications, benefits, and challenges.

Contents

What Are Prescription Digital Therapeutics?

Prescription digital therapeutics (PDTs) are a new class of medical interventions that leverage software to treat, manage, or prevent diseases and disorders. Unlike typical health apps, PDTs require a prescription from a healthcare provider and are subject to rigorous regulatory scrutiny.

According to the U.S. Food and Drug Administration (FDA), prescription digital therapeutics are medical devices, also called Software as a Medical Device (SaMD). The FDA review of prescription digital therapeutics is the same as the process the FDA uses to review medical devices. 

Definition and key characteristics of PDTs

PDTs are software-based treatments delivered through mobile devices, designed to address the behavioral and psychological aspects of various health conditions. These digital tools are developed based on scientific evidence and aim to provide therapeutic benefits comparable to traditional medical treatments (Phan et al., 2023). 

Source: Avalere

Examples of prescription digital therapeutics developers

This chart from Blue Matter Consulting (2023) lists 154 PDT companies.

Source: Blue Matter

How PDTs differ from wellness apps and other digital health tools

While wellness apps focus on general health and fitness, PDTs are designed to treat specific medical conditions. PDTs undergo clinical trials, and are subject to stringent regulatory processes to ensure they meet high standards of safety and effectiveness. This regulatory oversight differentiates PDTs from other digital health tools, which may not require such rigorous evaluation.

The PDT regulatory framework 

The FDA plays a critical role in the approval of PDTs. These therapeutics must demonstrate clinical efficacy and safety through rigorous trials before receiving FDA clearance. This process ensures that PDTs meet the same standards as traditional pharmaceuticals, providing healthcare providers and patients with confidence in their use (Phan et al., 2023).

The Science Behind Prescription Digital Therapeutics

PDTs are grounded in scientific research and evidence-based practices to ensure their effectiveness in treating various health conditions.

Evidence-based approaches used in PDTs

PDTs incorporate evidence-based approaches to help patients change their behaviors and manage symptoms effectively, such as: 

For instance, CBT-based PDTs can help identify and change negative thought patterns, improving mental health outcomes. A study on a PDT for opioid use disorder found it improved retention in treatment by 76% at 12 weeks compared to treatment as usual (Brezing & Brixner, 2022). 

Clinical trials and efficacy studies supporting PDTs

Lab worker

Clinical trials are essential for validating the efficacy of PDTs. These studies assess the therapeutic outcomes of PDTs compared to traditional treatments. 

For example, trials have shown PDTs can be effective in managing substance use disorders and chronic insomnia, providing real-world evidence of their clinical benefits (Brezing & Brixner, 2022).

Applications of Prescription Digital Therapeutics

PDTs offer promising solutions across a range of medical conditions, providing tailored interventions for diverse patient needs.

Mental health conditions

Therapist and patient talking on couch

PDTs are increasingly used to treat mental health disorders such as depression, anxiety, schizophrenia, and post-traumatic stress disorder (PTSD). In a randomized controlled trial, a PDT for depression reduced symptoms by 45.6% compared to 17.4% with usual treatment (Phan et al., 2023).

These digital tools provide accessible and scalable interventions, often with CBT techniques to help patients manage symptoms and improve their quality of life.

Chronic diseases

For chronic conditions like diabetes and hypertension, PDTs offer personalized management strategies. They enable continuous monitoring and data analysis, facilitating timely adjustments to treatment plans and improving patient outcomes (Phan et al., 2023).

A PDT for type 2 diabetes led to a 1.1% reduction in HbA1c levels after 6 months in a clinical trial (Phan et al., 2023).

Substance use disorders and addiction treatment

Woman sitting with hands clasped

PDTs are particularly effective in treating substance use disorders, offering structured programs that support recovery. They provide patients with tools to manage cravings and develop healthier coping mechanisms, contributing to sustained recovery. 

A couple of examples:

  • Research with 1,758 patients using a PDT for substance use disorder showed 64.1% abstinence at 12 months (Brezing & Brixner, 2022).
  • A PDT for alcohol use disorder resulted in 63% of patients reducing heavy drinking days compared to 32% receiving standard treatment (Rassi-Cruz et al., 2022).

Neurological disorders

Conditions such as ADHD and insomnia can benefit from PDTs, which offer targeted interventions to manage symptoms and improve daily functioning. For instance, PDTs for insomnia often include sleep hygiene education and relaxation techniques to enhance sleep quality.

Benefits of Prescription Digital Therapeutics

PDTs offer numerous advantages that enhance patient care and healthcare delivery.

Improved accessibility to treatment

PDTs make healthcare more accessible by providing treatments that can be delivered remotely via mobile devices. This is particularly beneficial for individuals in underserved areas or those with mobility challenges, ensuring they receive timely care.

Personalized and adaptive interventions

PDTs can be tailored to individual patient needs, offering adaptive interventions that evolve based on real-time data. This personalization enhances treatment effectiveness and patient satisfaction (Phan et al., 2023).

Real-time data collection and analysis

The ability to collect and analyze data in real-time allows healthcare providers to monitor patient progress continuously. PDTs can collect patient data continuously, providing 1440 data points per day compared to 1-4 from traditional in-person visits. This facilitates early detection of issues and enables proactive adjustments to treatment plans, improving overall outcomes (Phan et al., 2023).

Reduced healthcare costs

By providing effective and scalable interventions, PDTs have the potential to reduce healthcare costs. They can decrease the need for in-person visits and hospitalizations, making them a cost-effective alternative to traditional treatments. For example, an economic analysis estimated PDTs could save $2,150 per patient per year for opioid use disorder treatment (Brezing & Brixner, 2022).

Challenges and Limitations of PDTs

Despite their benefits, PDTs face several challenges that must be addressed to maximize their potential.

Doctor showing a patient an app in green

Federal regulation lags behind software development

Digital therapeutics (DTx) are mobile medical apps that use new tech like artificial intelligence (AI) and virtual reality (VR). They’re always changing, with new versions coming out every few months, which makes them hard to regulate. 

A problem with a DTx app could hurt someone’s health, so to keep DTx safe for consumers without stopping progress, software companies need to self-regulate–find ways to reduce risks and follow ethical rules on their own to help patients and build trust with their doctors.

One way to self-regulate is to involve clinicians in app development. Doctors know what patients need and can spot potential problems. But surprisingly, most health apps are made without input from medical experts. A study found only 20% of health apps included input from health professionals during development (Rassi-Cruz et al., 2022). 

Data privacy and security concerns

The collection and storage of sensitive health data raise significant privacy and security concerns. Ensuring robust data protection measures is crucial to maintaining patient trust and compliance with regulations (Phan et al., 2023).

Integration with existing healthcare systems

Integrating PDTs into existing healthcare infrastructures can be complex. Seamless integration is necessary to ensure that PDTs complement traditional treatments and fit within the broader healthcare ecosystem.

Patient adherence and engagement

Black man using his blood pressure monitor at home

Maintaining patient engagement with PDTs can be challenging. 

For example, take mental health apps that use CBT or provide feedback through wearables like smartwatches. While helpful, these apps often aren’t covered by insurance, and patients may pay out-of-pocket. They often give up if they don’t see quick results. 

Ensuring that patients adhere to prescribed digital therapies is essential for achieving desired outcomes, requiring strategies to enhance motivation and commitment. Pharmacists can help by encouraging patients to stick with the apps and complete all modules (Pharmacy Times, 2024).

Reimbursement and insurance coverage issues

Securing reimbursement for PDTs remains a hurdle, as insurance companies may be hesitant to cover these relatively new treatments. Establishing clear guidelines and demonstrating cost-effectiveness may help overcome this barrier.

The Future of Prescription Digital Therapeutics

The future of PDTs is promising, with advancements in technology and expanding applications poised to enhance their impact on healthcare.

overlay with doctor and pill bottle

Emerging technologies such as artificial intelligence and machine learning are set to revolutionize PDTs. These innovations can enhance personalization and predictive capabilities, improving treatment outcomes and patient experiences.

Potential for combination therapies

Combining PDTs with traditional treatments offers a holistic approach to healthcare. This synergy can enhance therapeutic outcomes by addressing multiple aspects of a patient’s condition, providing comprehensive care (Phan et al., 2023).

Expanding applications in preventive care and wellness

PDTs hold potential for preventive care by identifying and addressing health risks early. Their application in wellness can promote healthier lifestyles and prevent the onset of chronic diseases, contributing to improved public health.

Conclusion

In digital health, PDTs offer promising avenues for improving patient outcomes, increasing access to care, and potentially reducing healthcare costs. While challenges remain, the growing body of evidence supporting PDTs suggests that they will play an increasingly important role in the future of healthcare delivery. 

As patients, healthcare providers, and policymakers alike embrace these innovative tools, we can look forward to a more personalized, accessible, and effective approach to managing a wide range of health conditions.

References

Bashran, E. (2024). Prescription Digital Therapeutics: Devices. HealthAffairs. Retrieved from

https://www.healthaffairs.org/doi/10.1377/hlthaff.2024.00159

Brezing, C. A., & Brixner, D. I. (2022). The Rise of Prescription Digital Therapeutics In Behavioral Health. Journal of Behavioral Health; 11(4), 1-10. doi: 10.1007/s12325-022-02320-0 

Global Prescription Digital Therapeutics (PDTx) Market – Industry Trends and Forecast to 2030. (2023). Data Bridge Market Research. Retrieved from https://www.databridgemarketresearch.com/reports/global-prescription-digital-therapeutics-dtx-market

Liesch, J., Volgina, D. Nessim, C., Murphy, D., & Samson, C. (2023). Blue Matter Consulting. Retrieved from https://bluematterconsulting.com/prescription-digital-therapeutics-us-market-outlook-2023/

Phan, P., Mitragotri, S., & Zhao, Z. (2023). Digital therapeutics in the clinic. Bioengineering & Translational Medicine; 8(4), e10536. doi:10.1002/btm2.10536. 

Prescription Digital Therapeutics Bring New Treatments to Healthcare. (2021). Avalere Health. Retrieved from https://avalere.com/insights/prescription-digital-therapeutics-bring-new-treatments-to-healthcare

Prescription Digital Therapeutics for Mental Health: Effectiveness, Challenges, and Future Trends. (2024). Pharmacy Times. Retrieved from https://www.pharmacytimes.com/view/prescription-digital-therapeutics-for-mental-health-effectiveness-challenges-and-future-trends

Rassi-Cruz, M., Valente, F., & Caniza, M. V. (2022). Digital therapeutics and the need for regulation: How to develop products that are innovative, patient-centric and safe. Diabetology & Metabolic Syndrome; 14. doi.org/10.1186/s13098-022-00818-9 

Wang, C. Lee, C. & Shin, H. (2023). Digital therapeutics from bench to bedside. npj Digital Medicine; 6(1), 1-10. doi.org/10.1038/s41746-023-00777-z